2017 Not Looking As Bright As It Should Be For Turkish Pharma
Executive Summary
The pharmaceutical industry in Turkey has started 2017 cautiously despite a basically dynamic market and increasing demand for healthcare, with continued pricing and cost pressures, and political and economic instability, likely to dampen new investments.